The level of selling is routine and not economically significant relative to company size; no immediate trading signal. Monitor for escalation in volume or broader insider participation.
Price Chart
Executive Summary
Two insiders at Agios Pharmaceuticals sold shares in the past week, including the Chief Corporate Development & Strategy Officer and the Principal Accounting Officer, realizing $234,515 in open-market sales. The transactions were accompanied by non-cash derivative exercises. Total sales represent a negligible fraction of the company's $1.6B market cap.
Key Financial Metrics
Key Facts
- Viswanadhan Krishnan (Chief Corp Dev & Strategy) sold 2,959 shares for $82,260 and exercised derivatives for 16,200 shares (non-cash, $0 value).
- Theodore James Washburn (Principal Accounting Officer) sold 5,272 shares for $152,255.
- Total open-market sales: $234,515 across two insiders in the last 7 days.
- Sales represent only 0.015% of Agios's $1.6B market capitalization.
- No purchases or other cash-in transactions observed in the cluster.
Financial Impact
$234,515 in net insider selling over 7 days
Risk Factors
- Perception risk if additional insiders sell in coming weeks.
- Non-cash derivative exercises may lead to future selling pressure if shares are used to cover taxes or diversify holdings.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (4 trades, 7d window) | cluster-AGIO-1773087170152 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 144 | $36.85 | awaiting T+60 | — | $37.00 (+0.41%) |
Oct 22, 2026 4d ago | 144 | $37.00 | awaiting T+60 | — | $37.00 (0.00%) |
Aug 6, 2026 11w ago | Institutional Cluster | $31.95 | awaiting T+60 | — | $37.00 (+15.81%) |
Jul 30, 2026 12w ago | 8-K | $32.75 $37.00 | ▲ +12.98% | ▲ +10.51% | $37.00 (+12.98%) |
Jul 30, 2026 12w ago | Press Release | $32.75 $37.00 | ▲ +12.98% | ▲ +10.51% | $37.00 (+12.98%) |
Jul 7, 2026 15w ago | Press Release | $44.01 $33.25 | ▼ −24.45% | ▼ −26.44% | $37.00 (−15.93%) |
Jun 29, 2026 17w ago | Press Release | $38.04 $34.97 | ▼ −8.07% | ▼ −12.46% | $37.00 (−2.73%) |
Jun 18, 2026 18w ago | 8-K | $35.10 $32.81 | ▼ −6.52% | ▼ −8.27% | $37.00 (+5.41%) |
Jun 13, 2026 19w ago | Press Release | $31.82 $34.63 | ▲ +8.83% | ▲ +7.83% | $37.00 (+16.28%) |
Jun 1, 2026 21w ago | Press Release | $28.00 $33.90 | ▲ +21.07% | ▲ +19.84% | $37.00 (+32.14%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers